363 related articles for article (PubMed ID: 2838689)
1. Characteristics of flutamide action on prostatic and testicular functions in the rat.
Marchetti B; Labrie F
J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
[TBL] [Abstract][Full Text] [Related]
2. Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dog.
Lacoste D; Dubé D; Bélanger A; Labrie F
Mol Cell Endocrinol; 1989 Dec; 67(2-3):131-8. PubMed ID: 2693158
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3-week treatment with [D-Trp6, des-Gly-NH10(2)]LHRH ethylamide, aminoglutethimide, ketoconazole or flutamide alone or in combination on testicular, serum, adrenal and prostatic steroid levels in the dog.
Lacoste D; Caron S; Bélanger A; Labrie F
J Steroid Biochem; 1989 Aug; 33(2):233-42. PubMed ID: 2671505
[TBL] [Abstract][Full Text] [Related]
4. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
St Arnaud R; Lachance R; Dupont A; Labrie F
J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
[TBL] [Abstract][Full Text] [Related]
5. Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat.
Lefebvre FA; Séguin C; Bélanger A; Caron S; Sairam MR; Raynaud JP; Labrie F
Prostate; 1982; 3(6):569-78. PubMed ID: 6296803
[TBL] [Abstract][Full Text] [Related]
6. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
[TBL] [Abstract][Full Text] [Related]
7. The rise in testicular androgens during the first days of treatment with an LHRH agonist in the dog can be blocked by aminoglutethimide or ketoconazole.
Lacoste D; St-Arnaud R; Caron S; Belanger A; Labrie F
J Steroid Biochem; 1988 Dec; 31(6):963-70. PubMed ID: 3059065
[TBL] [Abstract][Full Text] [Related]
8. Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate.
Marchetti B; Poulin R; Plante M; Labrie F
J Steroid Biochem; 1988 Oct; 31(4A):411-9. PubMed ID: 2845194
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action and pure antiandrogenic properties of flutamide.
Labrie F
Cancer; 1993 Dec; 72(12 Suppl):3816-27. PubMed ID: 8252497
[TBL] [Abstract][Full Text] [Related]
10. Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen.
St-Arnaud R; Lachance R; Kelly SJ; Belanger A; Dupont A; Labrie F
Clin Endocrinol (Oxf); 1986 Jan; 24(1):21-30. PubMed ID: 3519004
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model.
Redding TW; Schally AV
Prostate; 1985; 6(3):219-32. PubMed ID: 3157927
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat.
Chandolia RK; Weinbauer GF; Simoni M; Behre HM; Nieschlag E
Acta Endocrinol (Copenh); 1991 Nov; 125(5):547-55. PubMed ID: 1759544
[TBL] [Abstract][Full Text] [Related]
13. Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophyseal testicular axis of the adult male rat and their incidences on fertility.
Viguier-Martinez MC; Hochereau de Reviers MT; Barenton B; Perreau C
Acta Endocrinol (Copenh); 1983 Oct; 104(2):246-52. PubMed ID: 6314726
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of pituitary-gonadal function in male rats by a potent GnRH antagonist.
Puente M; Catt KJ
J Steroid Biochem; 1986 Dec; 25(6):917-25. PubMed ID: 3025519
[TBL] [Abstract][Full Text] [Related]
15. A pure antiandrogen does not interfere with the LHRH agonist-induced blockade of testicular androgen secretion in the dog.
Lacoste D; St-Arnaud R; Bélanger A; Labrie F
Mol Cell Endocrinol; 1988 Mar; 56(1-2):141-7. PubMed ID: 3286322
[TBL] [Abstract][Full Text] [Related]
16. Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat.
Séguin C; Cusan L; Bélanger A; Kelly PA; Labrie F; Raynaud JP
Mol Cell Endocrinol; 1981 Jan; 21(1):37-41. PubMed ID: 6259002
[TBL] [Abstract][Full Text] [Related]
17. Role of adrenal androgens in prostate regression in rats treated with an antiandrogen and an LHRH agonist.
Foldesy RG; Vanderhoof MM; Canton LE; Hahn DW
Prostate; 1986; 9(3):227-35. PubMed ID: 3534825
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats.
Cusan L; Auclair C; Belanger A; Ferland L; Kelly PA; Seguin C; Labrie F
Endocrinology; 1979 May; 104(5):1369-76. PubMed ID: 220032
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.
Auclair C; Kelly PA; Coy DH; Schally AV; Labrie F
Endocrinology; 1977 Dec; 101(6):1890-3. PubMed ID: 201452
[TBL] [Abstract][Full Text] [Related]
20. Recovery of gonadal functions in the adult male rat following cessation of five-month daily treatment with an LHRH agonist.
Lefebvre FA; Bélanger A; Pelletier G; Labrie F
J Androl; 1984; 5(3):181-92. PubMed ID: 6086556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
